NCT00100633View on ClinicalTrials.gov

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

October 31, 2007

Conditions
HIV InfectionsHepatitis B
Interventions
DRUG

CpG7909 oligodeoxynucleotides (ODN)

BIOLOGICAL

Hepatitis B virus vaccine

Trial Locations (1)

44106

University Hospitals of Cleveland, Cleveland

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00100633 - Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People | Biotech Hunter | Biotech Hunter